Abstract
Monitoring the number of COVID-19 patients in hospital beds was a critical component of Australia’s real-time surveillance strategy for the disease. From 2021–2023, we produced short-term forecasts of bed occupancy to support public health decision making. In this work, we present a model for forecasting the number of ward and intensive care unit (ICU) beds occupied by COVID-19 cases. The model simulates the stochastic progression of COVID-19 patients through the hospital system and is fit to reported occupancy counts using an approximate Bayesian method. We do not directly model infection dynamics — instead taking independently produced forecasts of case incidence as an input — enabling the independent development of our model from that of the underlying case forecast(s). We evaluate the performance of 21-day forecasts of ward and ICU occupancy across Australia’s eight states and territories between March and September 2022, when major waves of the Omicron variant of SARS-CoV-2 were occurring throughout the country. Forecasts were on average biased downwards immediately prior to epidemic peaks and biased upwards post-peak. Forecast performance was best in jurisdictions with the largest population sizes. Our forecasts of COVID-19 hospital burden were reported weekly to national decision-making committees to support Australia’s public health response.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
Our forecasts used surveillance data reported through the Communicable Diseases Network Australia by the interim Australian CDC (previously the Office of Health Protection), Department of Health and Aged Care on behalf of the Communicable Diseases Network Australia (CDNA) as part of the nationally coordinated response to COVID-19. We additionally used surveillance data provided by the New South Wales Department of Health. We thank public health staff in state and territory health departments, the Australian Government Department of Health and Aged Care, and in state and territory public health laboratories. We thank members of CDNA for their feedback and perspectives on the results of the analyses. This work was directly funded by the Australian Government Department of Health and Aged Care. Additional support was provided by the National Health and Medical Research Council of Australia through its Investigator Grant Schemes (FMS Emerging Leader Fellowship, 2021/GNT2010051).
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Ethics committee of The University of Melbourne gave ethical approval for this work (2024-26949-50575-3).
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Data Availability
All code is available archived at OSF (http://osf.io/5e6ma/, DOI: 10.17605/OSF.IO/5E6MA). Changes to the model which occurred throughout the study period (which was limited to jurisdiction-specific modifications to sigma_hosp and sigma_los and a correction for New South Wales case data not including cases detected via rapid antigen test) are described in the supplementary materials (Supp.\ Methods S5). Limited data for reproducing the figures presented in this manuscript are also available at OSF (http://osf.io/5e6ma/, DOI: 10.17605/OSF.IO/5E6MA); this includes all model output forecast trajectories, reported occupancy counts retrieved from covid19data.com.au, case forecast performance metrics, and Approximate Bayesian Computation diagnostic plots as produced in the course of producing occupancy forecasts. The complete line listed case dataset is not publicly available; for access to the raw data, a request must be submitted to the Australian Government Department of Health and Aged Care which will be assessed by a data committee independent of authorship group.
